221 related articles for article (PubMed ID: 37107181)
21. Uterine fibroid size modifications during pregnancy and puerperium: evidence from the first systematic review of literature.
Vitagliano A; Noventa M; Di Spiezio Sardo A; Saccone G; Gizzo S; Borgato S; Vitale SG; Laganà AS; Nardelli GB; Litta PS; Saccardi C
Arch Gynecol Obstet; 2018 Apr; 297(4):823-835. PubMed ID: 29236171
[TBL] [Abstract][Full Text] [Related]
22. Spontaneous complete regression of large uterine fibroid after the second vaginal delivery: Case report.
Kim M
Medicine (Baltimore); 2018 Nov; 97(45):e13092. PubMed ID: 30407315
[TBL] [Abstract][Full Text] [Related]
23. Quality of life with relugolix combination therapy for uterine fibroids: LIBERTY randomized trials.
Stewart EA; Lukes AS; Venturella R; Li Y; Hunsche E; Wagman RB; Al-Hendy A
Am J Obstet Gynecol; 2023 Mar; 228(3):320.e1-320.e11. PubMed ID: 36370871
[TBL] [Abstract][Full Text] [Related]
24. Endometrial Angiogenesis of Abnormal Uterine Bleeding and Infertility in Patients with Uterine Fibroids-A Systematic Review.
Don EE; Middelkoop MA; Hehenkamp WJK; Mijatovic V; Griffioen AW; Huirne JAF
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108180
[TBL] [Abstract][Full Text] [Related]
25. Antitumor effect of the selective hypoxia-inducible factor-1 inhibitors echinomycin and PX-478 on uterine fibroids.
Xu L; Ishikawa H; Zhou Y; Kobayashi T; Shozu M
F S Sci; 2022 May; 3(2):187-196. PubMed ID: 35560016
[TBL] [Abstract][Full Text] [Related]
26. Uterine fibroid incidence and growth in an ultrasound-based, prospective study of young African Americans.
Baird DD; Patchel SA; Saldana TM; Umbach DM; Cooper T; Wegienka G; Harmon QE
Am J Obstet Gynecol; 2020 Sep; 223(3):402.e1-402.e18. PubMed ID: 32105679
[TBL] [Abstract][Full Text] [Related]
27. Uterine artery embolization in 101 cases of uterine fibroids: do size, location, and number of fibroids affect therapeutic success and complications?
Firouznia K; Ghanaati H; Sanaati M; Jalali AH; Shakiba M
Cardiovasc Intervent Radiol; 2008; 31(3):521-6. PubMed ID: 18219521
[TBL] [Abstract][Full Text] [Related]
28. Extracellular matrix and Hippo signaling as therapeutic targets of antifibrotic compounds for uterine fibroids.
Islam MS; Afrin S; Singh B; Jayes FL; Brennan JT; Borahay MA; Leppert PC; Segars JH
Clin Transl Med; 2021 Jul; 11(7):e475. PubMed ID: 34323413
[TBL] [Abstract][Full Text] [Related]
29. Evidence that geographic variation in genetic ancestry associates with uterine fibroids.
Keaton JM; Jasper EA; Hellwege JN; Jones SH; Torstenson ES; Edwards TL; Velez Edwards DR
Hum Genet; 2021 Oct; 140(10):1433-1440. PubMed ID: 34302236
[TBL] [Abstract][Full Text] [Related]
30. The Comparing Options for Management: PAtient-centered REsults for Uterine Fibroids (COMPARE-UF) registry: rationale and design.
Stewart EA; Lytle BL; Thomas L; Wegienka GR; Jacoby V; Diamond MP; Nicholson WK; Anchan RM; Venable S; Wallace K; Marsh EE; Maxwell GL; Borah BJ; Catherino WH; Myers ER
Am J Obstet Gynecol; 2018 Jul; 219(1):95.e1-95.e10. PubMed ID: 29750955
[TBL] [Abstract][Full Text] [Related]
31. Uterine perfusion model for analyzing barriers to transport in fibroids.
Stirland DL; Nichols JW; Jarboe E; Adelman M; Dassel M; Janát-Amsbury MM; Bae YH
J Control Release; 2015 Sep; 214():85-93. PubMed ID: 26184049
[TBL] [Abstract][Full Text] [Related]
32. Transcervical Radiofrequency Ablation of Uterine Fibroids Global Registry (SAGE): Study Protocol and Preliminary Results.
Christoffel L; Römer T; Schiermeier S
Med Devices (Auckl); 2021; 14():77-84. PubMed ID: 33688276
[TBL] [Abstract][Full Text] [Related]
33. [The percutaneous treatment of uterine fibromas by means of transcatheter arterial embolization].
Golfieri R; Muzzi C; De Iaco P; Maffei M; Giampalma E; Amore B; Muzzupapa G; Baroncini S; Bovicelli L
Radiol Med; 2000; 100(1-2):48-55. PubMed ID: 11109452
[TBL] [Abstract][Full Text] [Related]
34. Estrogen Receptors and Signaling in Fibroids: Role in Pathobiology and Therapeutic Implications.
Borahay MA; Asoglu MR; Mas A; Adam S; Kilic GS; Al-Hendy A
Reprod Sci; 2017 Sep; 24(9):1235-1244. PubMed ID: 27872195
[TBL] [Abstract][Full Text] [Related]
35. Relationship between a uterine fibroid diagnosis and the risk of adverse obstetrical outcomes: a cohort study.
Karlsen K; Schiøler Kesmodel U; Mogensen O; Humaidan P; Ravn P
BMJ Open; 2020 Feb; 10(2):e032104. PubMed ID: 32071172
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of ultrasound-guided high-intensity focused ultrasound (USgHIFU) for uterine fibroids: an observational single-center study.
Marinova M; Ghaei S; Recker F; Tonguc T; Kaverina O; Savchenko O; Kravchenko D; Thudium M; Pieper CC; Egger EK; Mustea A; Attenberger U; Conrad R; Hadizadeh DR; Strunk H
Int J Hyperthermia; 2021 Sep; 38(2):30-38. PubMed ID: 34420447
[TBL] [Abstract][Full Text] [Related]
37. Uterine fibroids: correlations between MRI appearance and stiffness via magnetic resonance elastography.
Jondal DE; Wang J; Chen J; Gorny KR; Felmlee J; Hesly G; Laughlin-Tommaso S; Stewart EA; Ehman R; Woodrum DA
Abdom Radiol (NY); 2018 Jun; 43(6):1456-1463. PubMed ID: 28952003
[TBL] [Abstract][Full Text] [Related]
38. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.
Lethaby A; Vollenhoven B; Sowter M
Cochrane Database Syst Rev; 2001; (2):CD000547. PubMed ID: 11405968
[TBL] [Abstract][Full Text] [Related]
39. Transcervical fibroid ablation with the Sonata™ system for treatment of submucous and large uterine fibroids.
Shifrin G; Engelhardt M; Gee P; Pschadka G
Int J Gynaecol Obstet; 2021 Oct; 155(1):79-85. PubMed ID: 33544889
[TBL] [Abstract][Full Text] [Related]
40. The management of uterine leiomyomas.
Vilos GA; Allaire C; Laberge PY; Leyland N;
J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
